Colorectal cancer
193 results
1 - 100
Palliative chemotherapy for advanced or metastatic colorectal cancer- Perioperative blood transfusions and recurrence of colorectal cancer
- Long‐term results of laparoscopic colorectal cancer resection
- Anti‐angiogenic therapies for metastatic colorectal cancer
- Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
- Screening for colorectal cancer using the faecal occult blood test, Hemoccult
- Blood CEA levels for detecting recurrent colorectal cancer
- Workload and surgeon´s specialty for outcome after colorectal cancer surgery
- Herbal medicines for advanced colorectal cancer: Cochrane systematic review
- Follow‐up strategies for patients treated for non‐metastatic colorectal cancer
- Duration of adjuvant chemotherapy for patients with non‐metastatic colorectal cancer
- Selective internal radiation therapy for liver metastases from colorectal cancer
- Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
- Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases
- Pre and peri‐operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.
- Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
- Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases
- Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer
- Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
- Oral versus intravenous fluoropyrimidines for colorectal cancer
- Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
- Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer
- Second-line systemic therapy for metastatic colorectal cancer: Cochrane systematic review
- Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery
- Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer
- Radiofrequency ablation in the treatment of liver metastases from colorectal cancer: Cochrane systematic review
- Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stage IV colorectal cancer: Cochrane systematic review
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression‐free survival in patients with advanced and/or metastatic colorectal cancer
- Contrast‐enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography‐computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer
- Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer: Cochrane systematic review
- Guaiac‐based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average‐risk individuals
- Narrow band imaging versus conventional white light colonoscopy for the detection of colorectal polyps: Cochrane systematic review
- Nonsteroidal anti‐inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas
- Curative surgery for obstruction from primary left colorectal carcinoma: Primary or staged resection?
- Colorectal stents for the management of malignant colonic obstructions
- Short term benefits for laparoscopic colorectal resection